Sort
85,873 grants matching “alzheimers”
Developing the Privately Owned Companion Dog as a Model for Alzheimers Disease
$1,274,292Christopher D Keene · University Of Washington · R24 · FY2022 · AG
ALZHEIMER'S DISEASE CORE CENTER
$1,274,260Linda J Van Eldik · University Of Kentucky · P30 · FY2009 · AG
New Approaches to Dementia Heterogeneity
$1,274,119University Of California San Francisco · P50 · FY2005 · AG
Quantitative Neuroimaging Assessment of White Matter Integrity in the Context of Aging and AD
$1,274,019Andreana Benitez · Medical University Of South Carolina · R01 · FY2023 · AG
Exerkines and the heterogeneity of peripheral and cerebral vascular adaptations to exercise training with aging in women and men
$1,274,001Kerrie Moreau · University Of Colorado Denver · R01 · FY2025 · AG
Prism-PET/EMMT: High resolution, cost effective, portable, and upright brain PET scanner for early diagnosis of Alzheimer's disease
$1,273,935Amirhossein Goldan · Weill Medical Coll Of Cornell Univ · U01 · FY2024 · AG
Protective factors and mechanisms
$1,273,857Doo Yeon Kim · Boston University Medical Campus · U19 · FY2022 · AG
Caregivers' Reactions and Experience: Imaging Dementia Evidence for Amyloid Scanning CARE IDEAS
$1,273,162Terrie F Wetle · Brown University · R01 · FY2019 · AG
SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT
$1,272,966Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Quantitative Neuroimaging Assessment of White Matter Integrity in the Context of Aging and AD
$1,272,785Andreana Benitez · Medical University Of South Carolina · R01 · FY2024 · AG
Alzheimer's Disease Core Center
$1,272,677Marek-Marsel M Mesulam · Northwestern University At Chicago · P30 · FY2014 · AG
Procurement and Characterization of Postmortem Brain Tissue
$1,272,522Joel Kleinman · National Institute Of Mental Health · ZIC · FY2012 · MH
Fusion Lumos Orbitrap System for Quantitative Proteomics and Metabolomics Applications
$1,272,480Nichole A Reisdorph · University Of Colorado Denver · S10 · FY2021 · OD
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$1,272,333Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2020 · AG
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease
$1,272,239Dmitry Gerashchenko · Boston Va Research Institute, Inc. · RF1 · FY2019 · AG
Data Management Core B
$1,271,988Jennifer A Alford-Teaster · Dartmouth College · P01 · FY2023 · AG
Northwell Roybal Center for Personalized Trials: Physical Activity Promotion for Persons Giving Care or Living with AD/ADRD
$1,271,724Karina W. Davidson · Feinstein Institute For Medical Research · P30 · FY2024 · AG
Alzheimer's Disease Research Center - Administrative Supplement 2025
$1,271,250Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2025 · AG
Genetic Analysis Of Alzheimer s Disease
$1,271,237Andrew Singleton · National Institute On Aging · ZIA · FY2019 · AG
Pathological and Functional Impact of Tauopathy in vivo
$1,271,138Karen E Duff · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · P01 · FY2007 · NS
Disambiguating natural aging from Alzheimer's disease through changes in oral neuromechanics
$1,271,131Fritzie Isip Arce-McShane · University Of Chicago · R01 · FY2021 · AG
NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease
$1,271,052Vactor Hadijah · Icahn School Of Medicine At Mount Sinai · N01 · FY2024 · MH
University of Kansas Alzheimer's Disease Core Center
$1,270,948Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2012 · AG
Prevention of Alzheimer's Diseae by Vitamin E and Selenium
$1,270,945Frederick Schmitt · University Of Kentucky · R01 · FY2012 · AG
University of Kansas Alzheimer's Disease Core Center
$1,270,006Russell H Swerdlow · University Of Kansas Medical Center · P30 · FY2014 · AG